insights_auto
Why is OCUL down 2.92%?
Dive Deeperchevron_right
OCUL:NASDAQ
Ocular Therapeutix Inc
$6.65
arrow_downward
-2.92%(-0.20) 1D
Nov 10, 10:26:00 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 8 analysts giving stock ratings to OCUL in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for OCUL in the last 3 months.
Highest
Current $6.65
$31.00 (+366.17%)
Average
$25.14 (+278.05%)
Lowest
$14.00 (+110.53%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Lisa Walter RBC Capital | Buy | Reiterated | $30.00 | +351.1% | 11/09/2026 |
Yi Chen H.C. Wainwright | Buy | Reiterated | $28.00 | +321.1% | 11/10/2026 |
Tazeen Ahmad Bank of America Securities | Buy | Reiterated | $27.00 | +306% | 11/09/2026 |
Serge Belanger Needham | Buy | Maintained | $18.00 | +170.7% | 11/10/2026 |
Biren Amin Piper Sandler | Buy | Maintained | $31.00 | +366.2% | 10/12/2026 |
Unknown Analyst UBS | Buy | Initiated | $14.00 | +110.5% | 10/11/2026 |
Alice Nettleton UBS | Buy | Initiated | $14.00 | +110.5% | 10/11/2026 |
Lachlan Hanbury Brown William Blair | Buy | Maintained | - | - | 09/25/2026 |
William Maughan Clear Street | Buy | Reiterated | $28.00 | +321.1% | 08/18/2026 |
Tara Bancroft TD Cowen | Buy | Maintained | $20.00 | +200.8% | 08/03/2026 |
Daniil Gataulin Chardan Capital | Buy | Maintained | $23.00 | +245.9% | 06/25/2026 |
Colleen M. Kusy Robert W. Baird | Buy | Maintained | $30.00 | +351.1% | 06/18/2026 |
Jonathan Wolleben Citizens JMP | Buy | Maintained | - | - | 02/17/2026 |
Clara Dong Jefferies | Buy | Maintained | $28.00 | +321.1% | 02/17/2026 |